A post-hoc analysis of follow-up data from the TRANSFORMS trial suggests that early disease activity during a patient’s first year on fingolimod predicts longer-term outcomes in multiple sclerosis. Click here to read the analysis by Pavle Repovic, a neurologist at the Swedish Multiple Sclerosis Center.
Most Recent Articles
Safety isn’t just our policy, it’s our culture
Safety is a core value at Swedish, and that's by design.
New operations hub will revolutionize care across Swedish
The Swedish Staffing, Transfer, and Operations Center will use advanced technology to ensure our patients get the right care at the right time at the right place. Learn more.
What to know about the Delta variant: Infectious disease experts weigh in
The COVID-19 Delta variant is quickly becoming the most common strain in the U.S. Discover how you can stay safe and protect your loved ones.
Caring for BIPOC and minority mental health
Access mental health resources at Swedish, and in our community
Depression before and after birth: You are not alone
Millions of women struggle with anxiety, depression and mental health issues during pregnancy and after childbirth. Find ways to cope.
Investing in our community to change lives
Learn why Swedish partners with local organizations to bring critical services into communities where help is needed most.
Do you know how to protect your skin from the summer sun?
Learn how to enjoy the sun safely – including how to protect against skin cancers such as melanoma – with these tips.
Lifting COVID-19 restrictions: Q&A with Swedish experts
With more people in Washington getting vaccinated, restrictions are lifting. Our experts discuss how to keep yourself and others safe.
Are you languishing?
Feeling a little blergh? Neither good nor sad and sort of on autopilot? Get tips from a behavioral health specialist to move from languishing to flourishing.
Pride Month Caregiver Spotlights
We're spotlighting some of our amazing caregivers and sharing what Pride Month means to them.
A cancer survivor's quest to help others beat chemo brain
National Cancer Survivors Day honors people like Katie Henry, who joined the VIBE study at Swedish to beat chemo brain. Here’s her story and memory strategies, too.
New research brings hope for detecting and preventing Alzheimer’s disease
A new blood test to detect Alzheimer’s disease is on the horizon, and recent research shows how you can lower your risk for the disease.
Working toward more compassionate and inclusive care for the LGBTQIA+ community
Learn how Swedish is taking steps to create a safer and more inclusive environment for gender-diverse patients through its LGBTQI+ Initiative.
Have you been putting off your annual men’s wellness exam?
What better way to celebrate Men’s Health Month than by scheduling much needed (and often dreaded) healthcare appointments?